Singapore markets closed

Syncom Formulations (India) Limited (SYNCOMF.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
13.95-0.05 (-0.36%)
At close: 03:30PM IST

Syncom Formulations (India) Limited

Syncom House
207, Saket Nagar Near Saket Club
Indore 452018
India
91 73 1270 0458
https://www.syncomformulations.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees555

Key executives

NameTitlePayExercisedYear born
Mr. Kedarmal Shankarlal Bankda M.ComExecutive Chairman7.1MN/A1952
Mr. Vijay Shankarlal Bankda B. Com LLBMD and Executive & Non Independent Director5.4MN/A1958
Mr. Ankit Kedarmal BankdaCFO & Additional Compliance OfficerN/AN/A1988
Mr. Rakesh Ch. SrivastavaVice President of MarketingN/AN/A1962
Ms. Payal Ankur BankdaVice President of Human ResourcesN/AN/A1987
Ms. Rinki Ankit BankdaWhole Time Director2.88MN/A1987
Vaishali AgrawalCompany Secretary & Compliance OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It also offers anemia tablet and syrup, lycopene, minerals and vitamins capsules, products for eradication of vaginal pathogens, capsules for the treatment of menopause, herbal uterine tonic, syrup for the treatment lactation insufficiency, cough suppressants, liver tonic, medicine for burning urination, and nutritional supplements. In addition, the company engages in the trading of commodities and renting of properties. Further, it exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Corporate governance

Syncom Formulations (India) Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.